I. Market Overview
In 2025, China's functional skincare market exceeded 150 billion yuan, and the medical aesthetics market exceeded 350 billion yuan. Driven by both consumption upgrading and favorable policies, the industry continues to maintain double-digit growth.
II. Five Major Trends
Trend 1: Accelerated substitution of recombinant collagen
With technological maturity and cost reduction, recombinant collagen is accelerating the substitution of animal-derived collagen. It is expected that by 2027, the penetration rate of recombinant collagen in the medical aesthetics market will exceed 60%.
Trend 2: Medicalization of functional skincare
Consumers are increasingly demanding efficacy from skincare products, and functional skincare products supported by clinical data are more favored. Medical device-grade skincare products have become a new growth point.
Trend 3: Personalized customization
Personalized skincare solutions based on technologies such as genetic testing and skin testing have become a trend. OEM/ODM companies need to possess stronger R&D and customization capabilities.
Trend 4: Accelerated overseas expansion
Chinese medical aesthetics brands and contract manufacturers are accelerating their overseas expansion, with emerging markets such as Southeast Asia and the Middle East becoming key expansion directions. The ability to register products in multiple languages and under multiple regulatory systems has become a core competitiveness.
Trend 5: Green and sustainable
As consumers' environmental awareness increases, green formulations, biodegradable packaging, and carbon-neutral production have become new industry standards.
III. Weitai Biotech's Strategic Layout
Having discussed the trends, let's talk about how Weitai Biotech has made its moves.
First, let's show our credentials: Weitai Biotech currently holds more than 110 registration certificates, has passed the GMPC+ISO dual certification system, owns 72 patented technologies, and its four production bases cover a total area of over 150,000 square meters. This production capacity scale is at the top level in the functional skincare and medical aesthetics contract manufacturing field.
In terms of full-process OEM/ODM services, Weitai's capability chain is very long—from independent R&D of active ingredients such as recombinant collagen, mussel adhesive protein, and ectoine at the raw material end, to formula design, efficacy verification, registration and application (domestic Class II medical devices + overseas registration), and then to large-scale mass production and finished product delivery. The entire chain is closed-loop in-house. Brand owners do not need to gather suppliers from everywhere; one Weitai can handle it all.
In terms of overseas expansion, we have accumulated rich registration experience in Southeast Asian and Middle Eastern markets. Our ability to register products in multiple languages and under multiple regulatory systems is becoming one of our core competitiveness. In terms of green production, all four production bases are advancing carbon-neutral transformation, and wastewater and exhaust gas treatment systems have all been upgraded to the latest standards.
IV. Weitai Solutions under the Trends
With the five major trends before us, what brand owners care about most is actually "how do I seize these opportunities." From the perspective of a contract manufacturer, Weitai will break this down for you:
Recombinant collagen substitution trend—Weitai's self-developed recombinant humanized type III collagen has a purity of ≥95% and has obtained multiple related registration certificates (Xiang Mech Registration No. 20222140503, Xiang Mech Registration No. 20242140072, Qiong Mech Registration No. 20252140091, etc.). Brand owners can directly launch products quickly based on mature solutions, saving the cycle of developing from scratch.
Medicalization trend of functional skincare—Weitai leads the industry in the number of Class II medical device registration certificates, helping brand owners obtain "medical device" status and back up product efficacy with clinical data, which is more persuasive than purely cosmetic products.
Personalized customization trend—The library of 2,000+ mature formulas is not just for show; it is a truly usable ammunition depot. For brand owners seeking differentiation, Weitai can quickly provide solutions, quickly produce samples, and quickly mass-produce.
Accelerated overseas expansion trend—Weitai already has overseas market registration experience and can help brand owners handle product registration and compliance documents in target countries, lowering the threshold for overseas expansion.
Green and sustainable trend—The green production systems of the four production bases are already operating maturely. If brand owners use Weitai for contract manufacturing, they will have solid content to talk about in ESG reports and brand stories.
V. Cooperation Cases
Having said so much, it is better to look at actual results. Weitai Biotech has so far served hundreds of brand clients. In terms of its own brands, Shitaqi, Shiweilandai, Beifuyinzi, and Yiweilan are all product lines within the Weitai system.
VI. Contact Us
Four Major Production Bases
- Guangzhou Weitai Factory: No. 77, She 15, Dalang Village, Baiyunhu Street, Baiyun District, Guangzhou City
- Guangdong Weitai Factory: No. 18, Taoyuan East Road, Songxia Industrial Park, Songgang, Shishan Town, Nanhai District, Foshan City
- Guangdong Jinan Gene Factory: Factory Building 23, Hongguang Industrial Park, No. 2 Wende Fifth Street, Zhaoqing High-tech Zone, Zhaoqing City, Guangdong Province
- Hunan Weitai Factory: Room 501, Building 11, Lanyuegu Intelligent Industrial Park, Xieyuan North Road, Ningxiang Economic Development Zone, Changsha City, Hunan Province
Brand owners are welcome to contact Weitai Biotech to discuss your product plans, and we will help you implement them.